摘要
ACP Journal Club17 January 2017Review: Pregabalin reduces fibromyalgia pain but increases adverse eventsMichael Yelland, MBBS, PhDMichael Yelland, MBBS, PhDGriffith University, Gold Coast, Queensland, Australia (M.Y.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2017-166-2-002 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationDerry S, Cording M, Wiffen PJ, et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016;9:CD011790. https://pubmed.ncbi.nlm.nih.gov/27684492Clinical Impact RatingsGIM/FP/GP: Neurology: Rheumatology: References1 Nasser K, Kivitz AJ, Maricic MJ, Silver DS, Silverman SL. Twice daily versus once nightly dosing of pregabalin for fibromyalgia: a double-blind randomized clinical trial of efficacy and safety. Arthritis Care Res (Hoboken). 2014;66:293-300. [PMID: 23983064] Google Scholar2 Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ. Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2015;10:CD008244. [PMID: 26482422] Google Scholar3 Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;1:CD007115. [PMID: 24385423] Google Scholar4 Moore RA, Cai N, Skljarevski V, Tölle TR. Duloxetine use in chronic painful conditions—individual patient data responder analysis. Eur J Pain. 2014;18:67-75. [PMID: 23733529] Google Scholar5 Gilron I, Chaparro LE, Tu D, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016;157:1532-40. [PMID: 26982602] Google Scholar Author, Article, and Disclosure InformationAffiliations: Griffith University, Gold Coast, Queensland, Australia (M.Y.)This article was published at Annals.org on 3 January 2017. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCitronellol, a monoterpene alcohol with promising pharmacological activities - A systematic reviewFibromyalgia and unexplained widespread pain: The idiopathic cerebrospinal pressure dysregulation hypothesis 17 January 2017Volume 166, Issue 2Page: JC2KeywordsAdverse eventsFibromyalgiaRelative riskRheumatic painRheumatologyRisk ratioSafetySerious adverse eventsSleepWeight gain ePublished: 17 January 2017 Issue Published: 17 January 2017 Copyright & PermissionsCopyright © 2017 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...